ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Gujarat Themis Biosyn initiated arbitration against Optimus Drugs claiming Rs. 90.24 Crore. The dispute involves breached 'Take-or-Pay' obligations and terminated supply agreements.
Gujarat Themis Biosyn amicably settled its commercial dispute with Optimus Drugs Private Limited. The arbitration disposal results in no material financial impact or penalties.
Gujarat Themis Biosyn initiated arbitration against Optimus Drugs claiming ₹90.24 Crore. The dispute follows a supply agreement termination and breach of take-or-pay obligations.
Gujarat Themis Biosyn faces an arbitration claim of ₹113.80 Crore from Optimus Drugs. The company expects no financial implication from this litigation.